BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35609001)

  • 1. Clinicopathological features and outcomes of thyroid nodules with EIF1AX mutations.
    Karslioglu French E; Nikitski AV; Yip L; Nikiforova MN; Nikiforov YE; Carty SE
    Endocr Relat Cancer; 2022 Aug; 29(8):467-473. PubMed ID: 35609001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and phenotypic correlations of EIF1AX mutations in thyroid nodules.
    Karunamurthy A; Panebianco F; J Hsiao S; Vorhauer J; Nikiforova MN; Chiosea S; Nikiforov YE
    Endocr Relat Cancer; 2016 Apr; 23(4):295-301. PubMed ID: 26911375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and Clinical Significance of EIF1AX Mutations and Co-Mutations in Cytologically Indeterminate Thyroid Nodules: A 5-Year Retrospective Analysis.
    Gargano SM; Badjatia N; Nikolaus Y; Peiper SC; Wang ZX
    Acta Med Acad; 2021 Apr; 50(1):4-12. PubMed ID: 34075760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EIF1AX mutation in thyroid tumors: a retrospective analysis of cytology, histopathology and co-mutation profiles.
    Elsherbini N; Kim DH; Payne RJ; Hudson T; Forest VI; Hier MP; Payne AE; Pusztaszeri MP
    J Otolaryngol Head Neck Surg; 2022 Nov; 51(1):43. PubMed ID: 36371345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suggesting the cytologic diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): A retrospective analysis of atypical and suspicious nodules.
    Strickland KC; Howitt BE; Barletta JA; Cibas ES; Krane JF
    Cancer Cytopathol; 2018 Feb; 126(2):86-93. PubMed ID: 28914983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of ThyroSeq Results with Surgical Histopathology in Cytologically Indeterminate Thyroid Nodules.
    Chin PD; Zhu CY; Sajed DP; Fishbein GA; Yeh MW; Leung AM; Livhits MJ
    Endocr Pathol; 2020 Dec; 31(4):377-384. PubMed ID: 32671653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The histologic outcomes of indeterminate thyroid nodules with rat sarcoma mutations: A case series.
    Jones M; Abendano DG; Turner M; Sullivan C; Reyes MCD
    Diagn Cytopathol; 2023 Dec; 51(12):E332-E337. PubMed ID: 37583345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic Characteristics of Thyroid Nodules Positive for the
    Morariu EM; McCoy KL; Chiosea SI; Nikitski AV; Manroa P; Nikiforova MN; Nikiforov YE
    Thyroid; 2021 Aug; 31(8):1212-1218. PubMed ID: 33487086
    [No Abstract]   [Full Text] [Related]  

  • 9. Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features Accounts for More Than Half of "Carcinomas" Harboring RAS Mutations.
    Paulson VA; Shivdasani P; Angell TE; Cibas ES; Krane JF; Lindeman NI; Alexander EK; Barletta JA
    Thyroid; 2017 Apr; 27(4):506-511. PubMed ID: 28114855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can cytology and the Thyroid Imaging, Reporting, and Data System (TI-RADS) identify noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) before surgery?
    Yang GCH; Fried KO; Scognamiglio T
    J Am Soc Cytopathol; 2020; 9(3):159-165. PubMed ID: 32111537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A thyroid EIF1AX story: how clinical, cytologic, and molecular surveillance led to appropriate management.
    Geisler DL; Karslioglu French E; Yip L; Nikiforova MN; Nikiforov YE; Schoedel KE; Seethala RR; Ohori NP
    J Am Soc Cytopathol; 2023; 12(2):105-111. PubMed ID: 36504010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilities of
    Guan H; Toraldo G; Cerda S; Godley FA; Rao SR; McAneny D; Doherty G; Braverman L; Lee SL
    Thyroid; 2020 Apr; 30(4):536-547. PubMed ID: 31996097
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytological, molecular, and clinical features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features versus invasive forms of follicular variant of papillary thyroid carcinoma.
    Zhao L; Dias-Santagata D; Sadow PM; Faquin WC
    Cancer Cytopathol; 2017 May; 125(5):323-331. PubMed ID: 28192645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ROLE OF MOLECULAR MARKERS IN THYROID NODULE MANAGEMENT: THEN AND NOW.
    Nikiforov YE
    Endocr Pract; 2017 Aug; 23(8):979-988. PubMed ID: 28534687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative Cytologic Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: A Prospective Analysis.
    Strickland KC; Vivero M; Jo VY; Lowe AC; Hollowell M; Qian X; Wieczorek TJ; French CA; Teot LA; Sadow PM; Alexander EK; Cibas ES; Barletta JA; Krane JF
    Thyroid; 2016 Oct; 26(10):1466-1471. PubMed ID: 27457786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative Role of RAS or BRAF K601E in the Guidance of Surgery for Indeterminate Thyroid Nodules.
    Ravella L; Lopez J; Descotes F; Giai J; Lapras V; Denier ML; Borson-Chazot F; Lifante JC; Decaussin-Petrucci M
    World J Surg; 2020 Jul; 44(7):2264-2271. PubMed ID: 32227276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative differentiation between noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) and non-NIFTP.
    Hahn SY; Shin JH; Lim HK; Jung SL; Oh YL; Choi IH; Jung CK
    Clin Endocrinol (Oxf); 2017 Mar; 86(3):444-450. PubMed ID: 27761926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TERT, HRAS, and EIF1AX Mutations in a Patient with Follicular Adenoma.
    Topf MC; Wang ZX; Tuluc M; Pribitkin EA
    Thyroid; 2018 Jun; 28(6):815-817. PubMed ID: 29669480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytological features of "noninvasive follicular thyroid neoplasm with papillary-like nuclear features" and their correlation with tumor histology.
    Maletta F; Massa F; Torregrossa L; Duregon E; Casadei GP; Basolo F; Tallini G; Volante M; Nikiforov YE; Papotti M
    Hum Pathol; 2016 Aug; 54():134-42. PubMed ID: 27085556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular testing for indeterminate thyroid nodules: Performance of the Afirma gene expression classifier and ThyroSeq panel.
    Jug RC; Datto MB; Jiang XS
    Cancer Cytopathol; 2018 Jul; 126(7):471-480. PubMed ID: 29637728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.